BrUOG 390: Neoadjuvant Treatment With Talazoparib

NCT04598321 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped termination of research grant agreement

Conditions

BRCA1 Mutation
BRCA2 Mutation
Ovarian Cancer
Fallopian Tube Cancer
High Grade Serous Carcinoma

Interventions

DRUG: Talazoparib Oral Capsule

Sponsor

Brown University

Collaborators

[object Object]
[object Object]